The global phospholipids market is anticipated to be worth US$1,766 million by 2023. It is expected to grow at a CAGR of 6.7% between 2023 and 2033. By 2033, the market is expected to be worth US$ 3,380.4 million.
Rising demand for natural phospholipids to be utilised in natural cosmetics as a result of the high preference for natural skin products, as well as the many health benefits provided by phospholipids in nutraceuticals and infant formulae, will drive sales in the phospholipids market.
The abundant availability of raw materials such as sunflower, rapeseed, milk, maize and so on, as well as the adaptability of phospholipids in a wide range of end use applications, are driving the expansion of the phospholipids market. Furthermore, the increased frequency of new product launches by leading companies is projected to drive phospholipid sales.
According to FMI’s geographical research, the United States is expected to dominate the global phospholipids market. Growth can be ascribed to consumer investments in personal care products, particularly skin care products, as well as the existence of important manufacturers, who anticipate a high demand in the coming years.
“Increasing demand for natural phospholipids and growth in the cosmetics industry, coupled with abundant raw material availability will create growth prospects for phospholipids market players through the projection period 2022-2032,” -says Nandini Roy Choudhury ( client Partner for Food and Beverages at Future Market Insights, Inc.)
Unlock Growth Potential in Your Industry – Get Your Sample Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14328
Key Takeaways:
- By product type, natural phospholipids is expected to account for more than 63.7% of total phospholipids market share in 2022.
- Sales of phospholipids applied in nutraceuticals is anticipated to hold about 43.7% of the total phospholipids market share in 2022.
- The U.S. is anticipated to hold a dominant share of 80.2% of the North America phospholipids market in 2022.
- China will remain as a lucrative market, creating an incremental opportunity of US$ 331.1 Mn in 2032.
- Germany is projected to account for 18.8% of the Europe phospholipids market share in 2032.
- China and Japan will hold 9.0% and 4.9% of the global phospholipids market share respectively in 2032.
Competitive Landscape
Leading players operating in the global phospholipids market include Avanti Polar Lipids Inc., Bunge Ltd., Cargill, Inc., Lecico GmbH, Lipoid GmbH, VAV Life Sciences Pvt. Ltd., Matreya, LLC, NOF CORPORATION, and others.
Leading players operating in the phospholipids market are engaging in strategic mergers and acquisitions, and are focusing on expansion of their production capacities. Apart from this, players are increasing investments in research and development to develop high quality phospholipids for different end use applications. For instance:
- In 2017, Larodan AB hired synthesis chemists for research and development of new lipid products or phospholipids, and sales and marketing coordinators to strengthen their relationship with international customers of phospholipids.
- In 2019 Avril Group manufacturer of oil and ingredient solutions acquired the Lecico GmbH to expand the business activities in Germany. By acquisition, the company aimed to enhance their product line and market coverage in the global level. As a result of acquisition Lecico GmbH launched two sunflower lecithin manufacturing plant in France and Romania.
Phospholipids Markey By Category
By Product Type :
- Natural
- Soybean
- Sunflower
- Rapeseed
- Egg
- Others (Milk, Peanuts, etc.)
- Synthetic
By Application :
- Cosmetics
- Skin Care
- Hair Care
- Pharmaceuticals
- Nutraceuticals
By Function :
- Emulsifiers
- Texturizers
- Stabilizers
- Binding Agents
- Releasing Agents
